Results 141 to 150 of about 37,220 (200)

A Case of Liver Injury Immediately After Initiation of Triple Therapy in a Patient With BRAF V600E Mutation-Positive Colorectal Cancer. [PDF]

Cureus
Aimono Y, Ohkawara A, Ogawa T, Yagisawa T, Tamura A.   +4 more
europepmc   +1 more source

<i>BRAF</i> V600E Mutation Has Variable Tumor-Specific Effects on Expression of MAPK Pathway Genes That Could Affect Patient Outcome. [PDF]

Int J Mol Sci
Darabi S, Stafford P, Braxton DR, Zuazo CE, Brodie TJ, Demeure MJ.   +5 more
europepmc   +1 more source

<i>BRAF</i> V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient. [PDF]

Gynecol Oncol Rep
Castaldi MA, Petrillo N, Selleri C, Ianniello M, Della Corte AM, Evangelista E, De Falco L, Sirica R, Casillo M, Caleo A, Caputo A, Zeppa P, Castaldi SG, Scala P, Serio B, Savarese G, Giudice V.   +16 more
europepmc   +1 more source

Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation. [PDF]

J Gastrointest Cancer
Ueberroth BE, Lieu CH, Lentz RW.
europepmc   +1 more source

Case report: Durable response from tegafur/gimeracil/oteracil (S-1) combined with fruquintinib and sintilimab as a third-line treatment for MSS metastatic colorectal cancer with a BRAF V600E mutation. [PDF]

Front Oncol
He C, Chi J, Du Z, Zhuang Z, Li L.
europepmc   +1 more source

The BRAF V600E Mutation and Clinicopathological Changes Among Patients With Hashimoto Thyroiditis, Papillary Thyroid Carcinoma With Hashimoto Thyroiditis, and Nodular Goiter. [PDF]

Appl Immunohistochem Mol Morphol
Deng J, Yu L, Luo S, Yang Z, Liu J, Liao L.   +5 more
europepmc   +1 more source

A combined model integrating deep learning, radiomics, and clinical ultrasound features for predicting <i>BRAF V600E</i> mutation in papillary thyroid carcinoma with Hashimoto's thyroiditis. [PDF]

Front Endocrinol (Lausanne)
Zhu PF, Zhang XF, Zhou P, Ben JY, Wang H, Zeng SE, Cui XW, He Y.   +7 more
europepmc   +1 more source

Clinical Implications of Cell-Free DNA in Managing <i>BRAF</i> V600E Mutation-Positive Colorectal Cancer. [PDF]

Genes (Basel)
Iwai T, Yamada T, Uehara K, Shinji S, Matsuda A, Yokoyama Y, Takahashi G, Miyasaka T, Yoshida H.   +8 more
europepmc   +1 more source

Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report. [PDF]

Thorac Cancer
Huang Z, Wang Y, Li B, Xu Y, Huang G, Song Y, Li J, Song L, Wang J, Wang R, Liang N, Li S.   +11 more
europepmc   +1 more source

Discordant Response to Nivolumab Plus Ipilimumab and Identification of <i>BRAF</i> V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case Report. [PDF]

JTO Clin Res Rep
Wilkins O, Omogbehin A, Bergquist PJ, Kim C, Liu SV, Reuss JE.   +5 more
europepmc   +1 more source